Global Drug Discovery Outsourcing Market By Drug Type (Small Molecule and Large Molecule), By Service Type (Target Identification & Screening, Target Discovery & Validation, Hit Identification/High-Throughput Screening, Hit-to-Lead Development, Lead Optimization, Preclinical Testing Services and Others), By Therapeutic Area (Oncology, Neurology/CNS Disorders, Infectious Diseases, Cardiovascular Diseases, Immunology & Inflammatory Disorders, Metabolic & Endocrine Disorders, Respiratory Diseases, Gastrointestinal Disorders, Rare/Orphan Diseases, Ophthalmology Diseases, Dermatology Diseases and Others), By End-User (Pharmaceutical & Biotechnology Companies and Academic & Research Institutes), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Dec 2025
- Report ID: 172190
- Number of Pages: 339
- Format:
-
keyboard_arrow_up
-
-
- IQVIA
- ICON plc
- Syneos Health
- Charles River Laboratories
- Labcorp
- WuXi AppTec
- Parexel
- Albany Molecular Research Inc.
- EVOTEC
- GenScript
- Thermo Fisher Scientific Inc.
- Merck & Co., Inc.
- Dalton Pharma Services
- Oncodesign
- Jubilant Biosys
- DiscoverX Corp.
- QIAGEN
- Eurofins SE
- Syngene International Limited
- Pharmaron Beijing Co., Ltd.
Our Clients
Kickstart 2026 with Exclusive Savings
✖
Request a Sample Report
We'll get back to you as quickly as possible